Bristol-Myers Squibb Shares Are Trading Higher. The Stock May Be Moving in Response to AbbVie After the Company Announced Its Two Phase 2 EMPOWER Trials Did Not Meet Its Primary Endpoint.
Bristol-Myers Squibb Shares Are Trading Higher. The Stock May Be Moving in Response to AbbVie After the Company Announced Its Two Phase 2 EMPOWER Trials Did Not Meet Its Primary Endpoint.
施貴寶股票交易走高。該股可能是在艾伯維公司公佈其兩項2期EMPOWER試驗未達到主要終點後做出的反應。
Bristol-Myers Squibb Shares Are Trading Higher. The Stock May Be Moving in Response to AbbVie After the Company Announced Its Two Phase 2 EMPOWER Trials Did Not Meet Its Primary Endpoint.
施貴寶股價上漲。股票可能是受到艾伯維公司的影響而走高，因爲公司宣佈其兩個2期EMPOWER試驗未達到主要終點。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間